Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Estrogen's oxytocin boost studied in rare hormone disorder

NCT ID NCT06460948

First seen May 13, 2026 · Last updated May 23, 2026 · Updated 2 times

Summary

This study measured how a single dose of oral estrogen affects oxytocin levels in 28 adults with arginine vasopressin deficiency (AVD) compared to healthy volunteers. Researchers also checked if oxytocin levels were linked to anxiety, depression, and quality of life. The goal was to better understand the body's hormone response, not to treat the condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARGININE VASOPRESSIN DEFICIENCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

Conditions

Explore the condition pages connected to this study.